Over the past 12 months, Century Therapeutics insiders bought $96,933 of stock on the open market (145.06K shares) and sold $86,186 (67.74K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Venture Capital Vi, L.P. Versant | TenPercentOwner | 11,452,014 | 0 | 11,452,014 | 63.1% | 11 Aug, 2022 |
| 2 | Brent Pfeiffenberger | President And Ceo | 3,633,839 | 0 | 3,633,839 | 20.0% | 15 Sep, 2026 |
| 3 | Chad Cowan | Chief Scientific Officer | 1,175,322 | 0 | 1,175,322 | 6.5% | 15 Jun, 2026 |
| 4 | Gregory Russotti | Officer | 509,198 | 0 | 509,198 | 2.8% | 15 Sep, 2026 |
| 5 | Douglas Carr | Svp Finance Operations | 502,907 | 0 | 502,907 | 2.8% | 15 Sep, 2026 |
| 6 | Luis Borges | Chief Scientific Officer | 256,535 | 0 | 256,535 | 1.4% | 05 Apr, 2023 |
| 7 | Michael Craig Diem | Chief Financial Officer | 253,533 | 0 | 253,533 | 1.4% | 03 Nov, 2023 |
| 8 | Adrienne Farid | Chief Operations Officer | 250,141 | 0 | 250,141 | 1.4% | 11 Jun, 2025 |
| 9 | Morgan Conn | Chief Finanical Officer | 79,648 | 0 | 79,648 | 0.4% | 12 Mar, 2025 |
| 10 | Hyam Levitsky | President Of Rd | 24,000 | 0 | 24,000 | 0.1% | 11 Mar, 2024 |
| 11 | Daphne Quimi | Director | 5,000 | 0 | 5,000 | 0.0% | 16 Sep, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 11 Sep, 2026 | Brent Pfeiffenberger | President And Ceo | Disposed F | 13,850 | $1.94 | $26.87K | 3,633,839 | Direct |
| 14 Sep, 2026 | Douglas Carr | Svp Finance Operations | Disposed S | 1,658 | $1.93 | $3.20K | 502,907 | Direct |
| 14 Sep, 2026 | Gregory Russotti | Officer | Disposed S | 2,587 | $1.93 | $4.99K | 509,198 | Direct |
| 09 Sep, 2026 | Joseph Truitt | Director | Acquired A | 148,000 | $0.00 | $0 | 148,000 | Direct |
| 08 Sep, 2026 | Douglas Carr | Svp Finance Operations | Disposed S | 254 | $2.05 | $521 | 504,565 | Direct |
| 08 Sep, 2026 | Gregory Russotti | Officer | Disposed S | 534 | $2.05 | $1.09K | 511,785 | Direct |
| 04 Sep, 2026 | Brent Pfeiffenberger | President And Ceo | Disposed F | 463 | $2.11 | $977 | 3,633,839 | Direct |
| 14 Aug, 2026 | Brent Pfeiffenberger | President And Ceo | Disposed F | 31,172 | $1.92 | $59.85K | 3,634,302 | Direct |
| 03 Aug, 2026 | Douglas Carr | Svp Finance Operations | Disposed S | 275 | $1.98 | $544 | 504,819 | Direct |
| 11 Jun, 2026 | Chad Cowan | Chief Scientific Officer | Disposed F | 358 | $2.24 | $802 | 1,175,322 | Direct |
| 12 Jun, 2026 | Gregory Russotti | Officer | Disposed S | 2,584 | $2.23 | $5.77K | 512,319 | Direct |
| 12 Jun, 2026 | Douglas Carr | Svp Finance Operations | Disposed S | 1,654 | $2.23 | $3.69K | 505,094 | Direct |
| 11 Jun, 2026 | Brent Pfeiffenberger | President And Ceo | Disposed F | 13,849 | $2.24 | $31.02K | 3,665,474 | Direct |
| 11 Jun, 2026 | Kimberly Blackwell | Director | Acquired A | 74,000 | $0.00 | $0 | 74,000 | Direct |
| 11 Jun, 2026 | Daphne Quimi | Director | Acquired A | 74,000 | $0.00 | $0 | 74,000 | Direct |
| 11 Jun, 2026 | Han Myung Lee | Director | Acquired A | 74,000 | $0.00 | $0 | 74,000 | Direct |
| 11 Jun, 2026 | Martin Patrick Murphy | Director | Acquired A | 74,000 | $0.00 | $0 | 74,000 | Direct |
| 11 Jun, 2026 | Alessandro Riva | Director | Acquired A | 74,000 | $0.00 | $0 | 74,000 | Direct |
| 08 Jun, 2026 | Douglas Carr | Svp Finance Operations | Disposed S | 249 | $2.11 | $526 | 506,748 | Direct |
| 05 Jun, 2026 | Brent Pfeiffenberger | President And Ceo | Disposed F | 463 | $2.13 | $986 | 3,679,323 | Direct |